Tuesday, July 6, 2021, 17:30 * Azrieli College for Engineering, the new bldg C, Room C206, 2d floor
with Davidi Vortman, CEO, UltraSight,
Eran Schenker, CMO, Merchavia
& Immanuel Lerner, CEO, Pepticom
Two top bio CEOs, that have successfully raised significant funding for their companies, as well as the CMO of an investment company specializing in investing in life science companies, are invited to share their insights about the challenges and pitfalls to avoid, in raising funding for a bio startup.
Presentations will be in English.
17:30 Registration and NETWORKING
18:00 Greetings – Hamutal Shahar, CEO, JLM-BioCity
– Prof Debbie Shalev, Hd, Pharma Engineering,
Azrieli College of Engineering
“Success in Fundraising for Bio Companies” –
* Davidi Vortman, CEO, UltraSight,
* Immanuel Lerner, CEO, Pepticom
* Eran Schenker, CMO, Merchavia
18:40 PANEL DISCUSSION
19:00 – 20:00 LOTS MORE NETWORKING
For the online participants, there will be one breakout room.
Please RSVP as soon as possible. You are requested to wear your mask during the event, from the beginning till the end. Green Passes need not be shown.
NOTE: We ask you for a 20 NIS donation at the entrance to the event. The JLM-BioCity Team are all volunteers, but we have expenses to cover. Thank you for your donation in advance.
ENTRANCE TO THE AZRIELI COLLEGE OF ENGINEERING WILL ONLY BE FOR PEOPLE WHO HAVE RVSP’ED AND SENT THEIR NAME IN HEBREW AND CAR LICENCE to https://forms.gle/hFznbNXp917WcSMr5
You can also get parking in the campus for your car.
The event can also be accessed by Zoom:
Meeting ID: 969 5719 9295
Find your local number anywhere in the world:
ABOUT OUR SPEAKERS
Davidi Vortman, CEO, UltraSight,
Davidi Vortman is UltraSight’s CEO. Prior to leading UltraSight, Davidi was the founder of Lumos Global, a disruptive solar technology company providing solar energy to off-grid rural communities. Prior to Lumos, Davidi served as an executive at Comverse Technologies and NICE Systems (NASDAQ: NICE). He holds a B.S.c in Computer Science from the Hebrew University and an MBA from Kellogg-Recanati.
Eran Schenker, CMO (Medical Director), Merchavia
Eran has over 20-year experience in technological and business development of companies dealing with medical equipment, pharmacology and bio-pharmaceutics. Dr. Schenker was medical director at Kamada, Neurim, and Neurolief.
Immanuel Lerner, CEO, Pepticom
Scientist and Biotech entrepreneur with a proven track record in envisioning and establishing a successful AI/biotech startup. Co-Invented, founded and currently leading Pepticom. Led Pepticom from concept to revenue generation via collaboration with large multinational companies, negotiated and executed multiple discovery deals and seed/Round A finance. A Merage Institute Business Executive Leadership Program alumni. Immanuel’s 15 year academic career prior to the establishment of Pepticom includes a Ph.D. in biochemistry followed by postdoctoral from the Hebrew University of Jerusalem.